钆类造影剂用于肿瘤靶向性成像

核磁共振成像(MRI)是肿瘤诊断的重要手段,特别是各种造影剂的使用加速了临床应用范围.目前临床MRI检查所用各类造影剂如Gd-DTPA-BMA、Gd-DOTA等均为小分子造影剂,存在组织特异性低、体内停留时间短等缺点.构建具有组织特异性的新一代高效、低毒MRI造影剂成为材料界、医学界的研究热点之一.本文在综合最新文献的...     

磁共振成像造影剂的研究进展

磁共振成像技术已成为临床医学影像学检查的重要手段,30%以上的磁共振成像诊断需要使用造影剂,因此磁共振成像造影剂也成为一种重要的临床诊断药物.本文简单介绍磁共振成像造影剂的定义、原理和分类,并对当前的研究进展进行了的评述,认为开发具有靶向性、高弛豫效率、使用安全的造影剂是研究的主要方向.     

可激活磁共振成像纳米探针的制备及生物医学应用

在生物医学领域,磁共振成像是一种非常重要的疾病诊疗技术.近50%的磁共振检查已经涉及造影剂的应用.可激活磁共振成像纳米探针以优化信噪比为原则,借助特异性的生物分子识别作用或分子交互作用增强磁共振信号,提高了磁共振诊断的敏感性与特异性,推动着磁共振成像在生物医学领域的广泛应用.本文就目前国内外热门研究的可激活磁共振纳米探针的种类、原理等方面进行阐述,详细介绍了可激活磁共振纳米探针在生物医学上的应用,在前景方面也进行了展望.     

肿瘤诊断的MRI造影剂*

磁共振成像是临床上常用的无侵入性肿瘤早期诊断手段,常常需要借助造影剂来提高诊断能力。造影剂可缩短质子的弛豫时间,间接地改变质子所产生的信号强度并能改变体内局部组织中水质子的弛豫速率,提高正常与患病部位的成像对比度。本文较系统地评述了目前国内外用于肿瘤成像造影剂的研究进展,并讨论了顺磁性造影剂的发展前景。     

pH响应的磁共振成像造影剂的研究进展

pH响应的磁共振成像(MRI)造影剂不仅能够对病变部位进行特异性增强成像,提高MRI检测疾病的灵敏度,而且可通过检测病变组织中的pH变化,为疾病的诊断提供依据。本文综述了pH响应的MRI造影剂的研究进展,介绍了其pH响应机理、种类与结构及应用,并对它的发展前景做了展望。     

多功能超声造影剂

与其他成像方法相比,超声成像具有成像效果好、实时成像、操作简便、无放射性污染、价格相对低廉、适用面广以及适用于床旁等诸多无法比拟的优点,因此是目前临床上应用最为广泛的成像诊断手段之一。临床上使用超声造影剂可以提高疾病诊断的准确性,但是,超声成像自身的缺点如灵敏度相对较低等使其在对癌症等重大疾病进行诊断时存在一定的局限性。将超声成像与其他成像模式联合使用则可实现优势互补,为临床诊断提供更快捷、更精确和更清晰的图像,为疾病的诊治提供更多的信息。同时,由于超声成像实时便捷的特性,使得超声成像特别适合与多种治疗方式结合在一起,开发超声成像实时监控治疗的复合试剂,即基于超声成像的诊断治疗一体化试剂。本文介绍了以超声成像为核心的多功能造影剂,包括靶向超声造影剂、多模态造影剂以及基于超声成像的诊断治疗一体化试剂,综述了近年来有关这一研究热点的报道,并提出了存在的问题以及今后可能的研究方向。     

肿瘤特异性多肽探针及其在生物成像中的应用

肿瘤是由细胞、细胞外基质及微环境等多因素组成的复杂系统,不同因素在肿瘤的发生和发展中发挥关键作用.肿瘤细胞、细胞外基质及微环境的特异性分析对于肿瘤的精准诊断和靶向治疗至关重要.多肽探针具有特异性高、生物相容性好、组织穿透能力强和易于制备等优点,已被广泛用于肿瘤的特异性成像研究.本文综述了多肽探针对肿瘤细胞、免疫细胞等细胞靶点的特异性成像;并介绍了以胶原蛋白、纤维蛋白等外基质蛋白为靶点的肿瘤特异性多肽探针的成像研究.本文还总结了对肿瘤微环境中弱酸性、高酶活性等因素响应的肿瘤特异性多肽探针及其生物成像应用.最后,本文总结并讨论了肿瘤特异性多肽探针所面临的挑战与机遇,展望了其在肿瘤精准诊断和个性化治疗领域的前景.     

氧化铁纳米颗粒在磁共振成像中的应用

目前临床诊断中钆基造影剂的应用十分广泛,然而其对人体的毒性无法忽视,因此研究者致力于低毒性造影剂的研发。氧化铁纳米颗粒(Iron Oxide Nanoparticles,IONP)因其超顺磁性在磁共振成像(Magnetic Resonance Imaging,MRI)中具有良好的暗对比效果,并且具有良好的生物相容性。随着生物材料和分子影像技术的发展,IONP在MRI成像中的应用愈发广泛。近年来,IONP在多模态成像和诊断治疗一体化方面取得了进展。本文将以IONP的MRI成像机理、制备和表面修饰为基础,阐述近年来IONP在MRI成像应用的研究成果和问题,期望IONP取得更好的发展。     

自组装多肽探针在磁共振成像中的应用

磁共振成像(MRI)是一种强大的非侵入式生物医学诊断技术. 临床上, MRI需要借助造影剂来提高成像质量, 从而提高诊断的准确性. 由于具有优越的信号放大能力和生物相容性, 自组装多肽探针可负载特定的MRI分子, 通过酶促自组装过程实现肿瘤靶向和特异性富集, 增强肿瘤病灶区MRI信号, 从而进一步提高MRI的准确性和灵敏度. 本综述总结了近年来多肽自组装探针在不同MRI模式( ¹H MRI, ¹⁹F MRI和双自旋核MRI)下的最新进展, 并展望了这类新型探针在MRI领域的应用前景.     

T1-T2双模式磁共振造影剂的设计及应用

核磁共振成像作为一种无侵入的早期诊断方式早已在临床上得到了非常广泛的应用,其成像方式分为弛豫加权和扩散加权,其中弛豫加权又分为T₁加权成像和T₂加权成像。为了增强MR图像对比度,可通过引入造影剂,根据其增强类型可以分为阳性的T₁造影剂和阴性的T₂造影剂。虽然两种造影剂各有其优点,但是也存在着一些不足,因此一种全新的T₁-T₂双模态造影剂应运而生。T₁-T₂双模态造影剂的优势就在于可以利用同一台仪器,实现MRI成像在时间和空间上的精确匹配。本文系统地总结了T₁-T₂双模态造影剂的设计思路和其化学合成方法,并对其生物医学应用作了介绍。     

In situ Activatable Peptide-based Nanoprobes for Tumor Imaging

Owing to its excellent biological properties, peptide has been widely used in the design of nanoprobes capable of enhancing tumor imaging signals. In recent years, a number of peptide-based nanoprobes with strong loading capacity and great biocompatibility have been developed for precision tumor imaging by coupling peptide motifs with different imaging agents. It is worth noting that, compared with "always on" mode, the use of stimulus-mediated in situ activatable mode to design and control the self-assembly or nanostructure transformation of peptide-based nanoprobes in vivo can achieve the significant improvement of imaging efficiency. Herein, we summarize the recent progress of in situ activatable peptide-based nanoprobes for tumor imaging in diverse imaging modes, including magnetic resonance imaging(MRI), fluorescence imaging(FI), photoacoustic imaging(PAI), radionuclide imaging(RI) and multimodal imaging. Finally, we briefly prospect the challenges and potential development directions of this field.     

Activatable fluorescence sensors for in vivo bio-detection in the second near-infrared window

Fluorescence imaging in the second near-infrared (NIR-II, 1000–1700 nm) window has exhibited advantages of high optical resolution at deeper penetration (ca. 5–20 mm) in bio-tissues owing to the reduced photon scattering, absorption and tissue autofluorescence. However, the non-responsive and “always on” sensors lack the ability of selective imaging of lesion areas, leading to the low signal-to-background ratio (SBR) and poor sensitivity during bio-detection. In contrast, activatable sensors show signal variation in fluorescence intensity, spectral wavelength and fluorescence lifetime after responding to the micro-environment stimuli, leading to the high detection sensitivity and reliability in bio-sensing. This minireview summarizes the design and detection ability of recently reported NIR-II activatable sensors. Furthermore, the challenges, opportunities and prospects of NIR-II activatable bio-sensing are also discussed.

Fluorescence imaging in the second near-infrared (NIR-II, 1000–1700 nm) window has exhibited advantages of high optical resolution at deeper penetration (ca. 5–20 mm) in bio-tissues owing to the reduced photon scattering and tissue autofluorescence.     

Maltohexaose-based probes for bacteria-specific imaging:Great sensitivity,specificity and translational potential

Infectious diseases have always been a major cause of mobility and mortality,early and accurate diagnosis is important for their management.However,current clinical diagnosis for bacterial infection still remains troublesome.Recently,many attempts on molecular imaging have been made for prompt bacteria detection,especially for early and precise disease diagnosis.Among them,maltohexaose-based probes serve as a superb candidate due to the bacteria-specific maltodextrin transport pathway.These probes can visualize bacterial foci with unparalleled sensitivity and specificity.Such metabolism-based targeting strategy offers a powerful delivery platform for imaging and theranostic agents,providing good translational potential for developing antibacterial agents.     

Imaging of Colorectal Cancers Using Activatable Nanoprobes with Second Near‐Infrared Window Emission

Fluorescent probes in the second near‐infrared window (NIR‐II) allow high‐resolution bioimaging with deep‐tissue penetration. However, existing NIR‐II materials often have poor signal‐to‐background ratios because of the lack of target specificity. Herein, an activatable NIR‐II nanoprobe for visualizing colorectal cancers was devised. This designed probe displays H₂S‐activated ratiometric fluorescence and light‐up NIR‐II emission at 900–1300 nm. By using this activatable and target specific probe for deep‐tissue imaging of H₂S‐rich colon cancer cells, accurate identification of colorectal tumors in animal models were performed. It is anticipated that the development of activatable NIR‐II probes will find widespread applications in biological and clinical systems.     

Spatially Resolved Quantification of Gadolinium(III)‐Based Magnetic Resonance Agents in Tissue by MALDI Imaging Mass Spectrometry after In Vivo MRI

Gadolinium(III)‐based contrast agents improve the sensitivity and specificity of magnetic resonance imaging (MRI), especially when targeted contrast agents are applied. Because of nonlinear correlation between the contrast agent concentration in tissue and the MRI signal obtained in vivo, quantification of certain biological or pathophysiological processes by MRI remains a challenge. Up to now, no technology has been able to provide a spatially resolved quantification of MRI agents directly within the tissue, which would allow a more precise verification of in vivo imaging results. MALDI imaging mass spectrometry for spatially resolved in situ quantification of gadolinium(III) agents, in correlation to in vivo MRI, were evaluated. Enhanced kinetics of Gadofluorine M were determined dynamically over time in a mouse model of myocardial infarction. MALDI imaging was able to corroborate the in vivo imaging MRI signals and enabled in situ quantification of the gadolinium probe with high spatial resolution.     

pH响应型近红外菁类荧光探针的合成及细胞成像

癌症的早期诊治是提高癌症患者治愈率的关键。但传统的"always on"型显影剂存在自身背景干扰且易造成"假阳性"等问题。本文利用肿瘤细胞具有弱酸性这一特性,设计合成了p H激活型不对称菁类荧光探针,并选用氨基葡萄糖作为修饰基团以增强探针母体的水溶性并赋予其肿瘤靶向性。该探针具有p H调控的"off-on"可逆的近红外荧光特性,以及与肿瘤弱酸性微环境相吻合的p H响应范围。此外,探针的浓度高达1.0×10~(-5)mol/L时仍未表现出明显的细胞毒性。该探针在细胞水平实现了肿瘤细胞弱酸性微环境的特异性成像。     

Multilayered Activatable Nanoprobe for Ultra‐Bright Tumor Imaging

The development of tumor targeted probes with strong signal and high contrast is always challenging in cancer imaging. Here, a unique multilayered activatable nanoprobe (MAN) is prepared to fulfill this long‐standing goal. MAN adopts a versatile layer‐by‐layer fabrication technique that sequentially assembles multifunctional polyelectrolytes onto nanoparticles via charge‐charge interaction. Unlike the common one‐probe‐one‐fluorochrome construct, MAN offers a dramatic fluorescence enhancement by transporting a large quantity of quenched fluorochromes for maximal signal and contrast. Excellent signal amplification and retention with negligible cytotoxicity is observed in cell study. Upon systemic injection into mice, MAN quickly accumulates in tumor and its fluorescent signal is turned on by proteases overexpressed in tumors, resulting in >700% tumor‐to‐normal‐tissue contrast. This multilayered fabrication provides a simple and powerful universal platform to design sensitive tumor imaging probes.     

磁共振/光学双模态分子探针的研究现状与展望

基于磁共振与荧光成像的双模态成像技术不仅克服了传统单一分子影像技术在灵敏度、特异度、分辨率等方面的固有缺陷，更是拓宽了分子影像技术在诊断及治疗监控等领域的研究范围及应用前景。本文将对磁共振/荧光双模态分子探针的应用情况和研究进展等进行综述。     

Recent advances in the development of activatable multifunctional probes for in vivo imaging of caspase-3

Caspases are a family of proteases that play critical roles in controlling inflammation and cell death.Apoptosis is a caspase-3 mainly controlled behavior to avoid inflammation and damage to surrounding cells,whereas anomalistic cell apoptosis may be associated with many diseases.The detection and imaging of caspase-3 will be of great significance in evaluating the early therapeutic effect of tumors.Developing smart fluorescent probes may be helpful for the visualization of the rapeutic effect compared with "always on" probes.Thus,more and more works toward activatable fluorescent probes for caspase-3 imaging have been reported.In addition,multifunctional probes have also been designed to further improve the imaging of caspase-3.Herein,this review systematically summarized the representative wo rk of caspase-3 from the perspective of molecular design that it will play a guiding role in the design of probes that respond to caspase-3.Also,challenges and perspectives toward the field for imaging of cell apoptosis(caspase-3) are also discussed.     

A pH-Sensitive Zwitterionic Iron Complex Probe with High Biocompatibility for Tumor-Specific Magnetic Resonance Imaging

Accurate diagnosis of tumor characteristics, including its location and boundary, is of immense value to subsequent therapy. Activatable magnetic resonance imaging (MRI) contrast agents that respond to tumor-specific microenvironments, such as the redox state, pH, and enzyme activity, enable better mapping of tumor tissue. However, the practical application of most reported activatable agents is hampered by problems including potential toxicity, inefficient elimination, and slow activation. In this study, we developed a zwitterionic iron complex (Fe-ZDS) as a positive MRI contrast agent for tumor-specific imaging. Fe-ZDS could dissociate in weakly acidic solution rapidly, accompanied by clear longitudinal relaxivity (r₁) enhancement, which enabled the complex to act as a pH-sensitive contrast agent for tumor-specific MR imaging. In vivo experiments showed that Fe-ZDS rapidly enhanced the tumor-to-normal contrast ratio by >40 %, which assisted in distinguishing the tumor boundary. Furthermore, Fe-ZDS circulated freely in the bloodstream and was excreted relatively safely via kidneys owing to its zwitterionic nature. Therefore, Fe-ZDS is an ideal candidate for a tumor-specific MRI contrast agent and holds considerable potential for clinical translation.